MonTa Biosciences ApS
CVR 36697016 · Private limited company (ApS) · Active · Medium risk
MonTa Biosciences ApS is a Private limited company (ApS), founded on , based in Kongens Lyngby. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. 10 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -10.3m and a net result of DKK -4.8m.
Bankruptcy risk for MonTa Biosciences ApS
1.4 × the average (1.41%) · higher risk than 84% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 36697016
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (11 years)
- Address
- Diplomvej 377, 1.
2800 Kongens Lyngby - Municipality
- Lyngby-Taarbæk
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 2.6m
- Employees
- 1 (2018)
- Auditor
- Grant Thornton, Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 10 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -9.9% |
| Current ratio | 680% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 30 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 1.8m | DKK 1.5m | DKK 2.0m |
| Net profit | DKK -4.8m | DKK -3.9m | DKK -3.3m |
| Equity | DKK -10.3m | DKK -5.5m | DKK -1.6m |
| Total assets | DKK 103.7m | DKK 83.4m | DKK 74.0m |
| Cash | DKK 8.1m | DKK 6.9m | – |
| Short-term debt | DKK 1.5m | DKK 1.5m | – |
| Avg. employees | 3 | 3 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Grant Thornton, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 139 | ||
| 1 Jan 2024 – 31 Dec 2024 | 133 | ||
| 1 Jan 2023 – 31 Dec 2023 | 136 | ||
| 1 Jan 2022 – 31 Dec 2022 | 104 | ||
| 1 Jan 2021 – 31 Dec 2021 | 109 | ||
| 1 Jan 2020 – 31 Dec 2020 | 102 | ||
| 1 Jan 2019 – 31 Dec 2019 | 112 | ||
| 1 Jan 2018 – 31 Dec 2018 | 98 | ||
| 1 Jan 2017 – 31 Dec 2017 | 75 | ||
| 26 Mar 2015 – 30 Jun 2016 | 153 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Thomas Lars Andresen | ||
| Board | Esper Boel | Current | |
| Board | Sven Madsen | Current | |
| Board | Lone Schøtt Kunøe | Current | |
| Board | Søren Tulstrup | Current | |
| Board | Thomas Lars Andresen | ||
| Board | Peter Birk Rasmussen | ||
| Board | Lone Schøtt Kunøe | ||
| Board | Peter Birk Rasmussen | ||
| Owner (5%) | Jonas Rosager Henriksen | Current | |
| Owner (10%) | TLA-HOLDING 2010 ApS | Current | |
| Owner (15%) | JENSEN BIOCONSULT ApS | Current | |
| Owner (50%) | Consolidated Biosciences ApS | Current | |
| Owner (15%) | Jonas Rosager Henriksen | ||
| Owner (5%) | Ladan Roursgaard | ||
| Owner (25%) | TLA-HOLDING 2010 ApS | ||
| Owner (33%) | JENSEN BIOCONSULT ApS | ||
| Owner (10%) | Jonas Rosager Henriksen | ||
| Owner (10%) | Anders Elias Hansen | ||
| Owner (10%) | Jonas Rosager Henriksen | ||
| Owner (5%) | Ladan Roursgaard | ||
| Owner (5%) | Anders Elias Hansen | ||
| Owner (25%) | TLA-HOLDING 2010 ApS | ||
| Owner (33%) | JENSEN BIOCONSULT ApS | ||
| Owner (20%) | TLA-HOLDING 2010 ApS | ||
| Owner (25%) | JENSEN BIOCONSULT ApS | ||
| Owner (20%) | Uddannelses- og Forskningsstyrelsen | ||
| Owner (10%) | TLA-HOLDING 2010 ApS | ||
| Owner (10%) | Uddannelses- og Forskningsstyrelsen | ||
| Owner (15%) | JENSEN BIOCONSULT ApS | ||
| Owner (33%) | Consolidated Biosciences ApS | ||
| Owner (10%) | TLA-HOLDING 2010 ApS | ||
| Owner (15%) | JENSEN BIOCONSULT ApS | ||
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | Current | |
| Founder | Jonas Rosager Henriksen | Current | |
| Founder | Ladan Roursgaard | Current | |
| Founder | TLA-HOLDING 2010 ApS | Current | |
| Founder | JENSEN BIOCONSULT ApS | Current |
The CEOs' other companies
Thomas Lars Andresen – 4 other companies
- Commit Biologics ApS Active
- NANOVI A/S Active
- NR HOLDING JUN-2010 ApS Opløst
- Precision Antibiotics ApS Active
Address history (2 moves)
| Diplomvej 377, 1., 2800 Kongens Lyngby | |
| c/o Simon Skjøde Jensen, Diplomvej 377, 1., 2800 Kongens Lyngby | |
| c/o Simon Skjøde Jensen, Kagsløkke 1, 2700 Brønshøj |
Former names
| MonTa Biosciences ApS | – now |
| MonTa Biosciences IVS | – |
Employees per year
Other companies at the same address
- AWS TECHNOLOGY A/S Bankrupt
- IIBOX TECHNOLOGIES ApS Bankrupt
- Movesca ApS Bankrupt
- Movesca Holding ApS Bankrupt
- NIKOLAJSEN NET ApS Bankrupt
- PRINT ASSOCIATES A/S Bankrupt
- UDVIKLINGSSELSKABET AF 1. OKTOBER 2007 ApS Bankrupt
- ABH Optics ApS Active
- AMP DANMARK A/S Active
- CPI Dashboard ApS Opløst
- EPITAL ApS Opløst
- EUROPEAN HYDRO PLANTS A/S Fusioneret
- EUROPEAN HYDRO PLANTS SOUTHEAST EUROPE ApS Fusioneret
- EUROPEAN SOLAR FARMS SPAIN II A/S Opløst
- EUROPEAN WIND FARM NO. 1 A/S Fusioneret
- IPTECTOR CONSULTING ApS Active
- IPTector Assets ApS Active
- InnoConsult ApS Opløst
- LUMION ApS Opløst
- LYKKE & PARTNERS RESEARCH ApS Compulsorily dissolved
- Mogens Weel Holding ApS Active
- NAES INVEST ApS Fusioneret
- Plexar Optimization ApS Active
- SITERAY ApS Active
- SRIT Holding3 ApS Active
Similar companies in Lyngby-Taarbæk
- Munro Consulting ApS Kongens Lyngby
- Nykode Tolerance A/S Kongens Lyngby
- Mycoverse ApS Kongens Lyngby
- Enzidia ApS Kongens Lyngby
- Novo Nordisk Foundation Cellerator A/S Kongens Lyngby
- KLMBio ApS Virum
- MCT Bioseparation Aps Kongens Lyngby
- VenomAid Diagnostics ApS Kongens Lyngby
- Valinor Aps Kongens Lyngby
- GeCo ApS Kongens Lyngby
- Selma Diagnostics ApS Kongens Lyngby
- BACTICON ApS Kgs. Lyngby
Questions and answers about MonTa Biosciences ApS
Has MonTa Biosciences ApS gone bankrupt?
No, MonTa Biosciences ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of MonTa Biosciences ApS?
Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.
Who is the auditor of MonTa Biosciences ApS?
MonTa Biosciences ApS most recently used Grant Thornton, Godkendt Revisionspartnerselskab.
When was MonTa Biosciences ApS founded?
MonTa Biosciences ApS was founded on 25 March 2015.
What is the equity of MonTa Biosciences ApS?
Equity was DKK -10.3m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.